Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 297 participants.
Also called NCT04798768
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 297 participants
- Sponsor
- Registry
-
NCT04798768
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States, Austria, Canada, Czechia, France, Italy, Netherlands, Spain, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04798768. Allocation not applicable; no masking; primary purpose treatment. Start 2021-07-20 (actual); primary completion 2024-05-06 (actual). Results posted on 2025-06-26.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing
- Acronym
- MODULAR ATP
- Condition
- Tachycardia, Ventricular
- Condition
- Arrhythmia, Ventricular
- Intervention (Device)
- mCRM Therapy System
- Lead sponsor
- Boston Scientific Corporation
Record details
- Record id
cardio:ct-nct04798768- Content hash
2a73ceb6ec070fc5dcc0ff9dab81758740d7c84eed058cc2138bfb5ca60c61d8